AllianceBernstein
TSVT

AllianceBernstein’s 2seventy bio TSVT Stock Holding History

AllianceBernstein’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65,973
Closed -$326K – 3336
2025
Q1 		$326K Sell
65,973
-3
-0% -$10 ﹤0.01% 2734
2024
Q4 		$194K Hold
65,976
– – ﹤0.01% 3030
2024
Q3 		$311K Hold
65,976
– – ﹤0.01% 2899
2024
Q2 		$254K Buy
65,976
+16,680
+34% +$75.2K ﹤0.01% 2973
2024
Q1 		$264K Sell
49,296
-7,830
-14% -$36.8K ﹤0.01% 2849
2023
Q4 		$244K Sell
57,126
-273
-0.5% -$839 ﹤0.01% 2920
2023
Q3 		$225K Hold
57,399
– – ﹤0.01% 2915
2023
Q2 		$581K Buy
57,399
+22,224
+63% +$235K ﹤0.01% 2553
2023
Q1 		$359K Sell
35,175
-266
-0.8% -$3.04K ﹤0.01% 2702
2022
Q4 		$332K Hold
35,441
– – ﹤0.01% 2830
2022
Q3 		$516K Buy
35,441
+4,000
+13% +$59.4K ﹤0.01% 2633
2022
Q2 		$415K Buy
31,441
+7,666
+32% +$104K ﹤0.01% 2757
2022
Q1 		$406K Sell
23,775
-4,300
-15% -$72.9K ﹤0.01% 2762
2021
Q4 		$720K Buy
+28,075
New +$876K ﹤0.01% 2588

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AllianceBernstein's TSVT Position: Q2 2025 in Review

AllianceBernstein sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 65,973 shares — an estimated $326K sold.

AllianceBernstein first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $720K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • AllianceBernstein reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 65,973 2seventy bio shares in Q2 2025, an estimated $326K.
  • AllianceBernstein first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • AllianceBernstein's 2seventy bio position peaked at $720K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.